RE: The Future7 May 2020 21:14
Correct me if I'm wrong but doesn't this statement mean that it's in Hercules intrest for "Mofit Bio" to succeed
"As agreed at Motif Bio's general meeting, the company will grant Hercules warrants over a total of 121.3 million ordinary shares, representing 25% of its outstanding share capital. These expire January 2021 and have a 0.42 pence per share exercise price."